PROVIDER PROFILE · NPI 1932186772

Benjamin SolkyM.D.

DermatologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

4,349

Unique beneficiaries

—

Total services

6,151

Distinct HCPCS

Medicare payment

$1.6M

Peer benchmark

Total Medicare services vs. 478 Dermatology providers in MA — top quintile (cohort median 1,835).

PRESCRIBING · PART D · 2024

Total Rx claims

759

Beneficiaries

—

Total drug cost

$7K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Cephalexin567 claims

Doxycycline Hyclate74 claims

Doxycycline Monohydrate53 claims

Triamcinolone Acetonide20 claims

Clobetasol Propionate16 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

REFERRAL NETWORK

Where Benjamin Solky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Hongmei Li Pathology · Weston, MA	234	396
THE GENERAL HOSPITAL CORPORATION	38	67
Katherine Masterpol Dermatology · Burlington, MA	19	30
Karen Wu Pathology · Portsmouth, NH	18	22
Joshua Shofner Dermatology · Winchester, MA	18	24
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	18	31
Christy Williams Dermatology · Westford, MA	13	37
Donna Kulas Nurse Practitioner · Concord, MA	13	14

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history